AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.030
-0.020 (-1.90%)
Feb 18, 2026, 4:00 PM EST - Market closed
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $28.22 million as of February 19, 2026. Its market cap has decreased by -17.14% in one year.
Market Cap
28.22M
Enterprise Value
-33.70M
1-Year Change
-17.14%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $28.22M, a decrease of -89.96%. That is a compound annual growth rate of -44.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 28.77M | -7.89% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 31.73M |
| Reviva Pharmaceuticals Holdings | 30.45M |
| Lantern Pharma | 30.20M |
| Kyntra Bio | 30.14M |
| Dyadic International | 30.04M |
| Rein Therapeutics | 29.44M |
| BriaCell Therapeutics | 29.28M |
| Passage Bio | 28.00M |